107 related articles for article (PubMed ID: 15576322)
1. Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential.
Kido H; Okumura Y; Yamada H; Mizuno D; Higashi Y; Yano M
Biol Chem; 2004 Nov; 385(11):1029-34. PubMed ID: 15576322
[TBL] [Abstract][Full Text] [Related]
2. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
3. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T
Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355
[TBL] [Abstract][Full Text] [Related]
4. Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells.
Yamaya M; Shinya K; Hatachi Y; Kubo H; Asada M; Yasuda H; Nishimura H; Nagatomi R
J Pharmacol Exp Ther; 2010 Apr; 333(1):81-90. PubMed ID: 20040578
[TBL] [Abstract][Full Text] [Related]
5. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.
Kido H; Niwa Y; Beppu Y; Towatari T
Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754
[TBL] [Abstract][Full Text] [Related]
6. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
Tamura S; Kurata T
Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
[TBL] [Abstract][Full Text] [Related]
7. Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.
Le TQ; Kawachi M; Yamada H; Shiota M; Okumura Y; Kido H
Biol Chem; 2006 Apr; 387(4):467-75. PubMed ID: 16606346
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of mini-plasmin in the cerebral capillaries causes vascular invasion of the murine brain by a pneumotropic influenza A virus: implications for influenza-associated encephalopathy.
Yao D; Chen Y; Kuwajima M; Shiota M; Kido H
Biol Chem; 2004 Jun; 385(6):487-92. PubMed ID: 15255180
[TBL] [Abstract][Full Text] [Related]
9. Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure.
Kido H; Okumura Y; Takahashi E; Pan HY; Wang S; Yao D; Yao M; Chida J; Yano M
Biochim Biophys Acta; 2012 Jan; 1824(1):186-94. PubMed ID: 21801859
[TBL] [Abstract][Full Text] [Related]
10. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection.
Tsurita M; Kurokawa M; Imakita M; Fukuda Y; Watanabe Y; Shiraki K
J Pharmacol Exp Ther; 2001 Jul; 298(1):362-8. PubMed ID: 11408563
[TBL] [Abstract][Full Text] [Related]
11. Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels.
Yang B; Yao DF; Ohuchi M; Ide M; Yano M; Okumura Y; Kido H
Eur Respir J; 2002 May; 19(5):952-8. PubMed ID: 12030738
[TBL] [Abstract][Full Text] [Related]
12. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
13. Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses.
Beppu Y; Imamura Y; Tashiro M; Towatari T; Ariga H; Kido H
J Biochem; 1997 Feb; 121(2):309-16. PubMed ID: 9089405
[TBL] [Abstract][Full Text] [Related]
14. [Various sides of influenza, part I--structure, replication, changeability of influenza viruses, clinical course of the disease, immunological response and laboratory diagnostics].
Machała MK; Brydak LB
Pol Merkur Lekarski; 2006 Sep; 21(123):270-6. PubMed ID: 17163190
[TBL] [Abstract][Full Text] [Related]
15. Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options.
Kido H; Takahashi E; Kimoto T
Biochimie; 2019 Nov; 166():203-213. PubMed ID: 31518617
[TBL] [Abstract][Full Text] [Related]
16. Aprotinin and similar protease inhibitors as drugs against influenza.
Zhirnov OP; Klenk HD; Wright PF
Antiviral Res; 2011 Oct; 92(1):27-36. PubMed ID: 21802447
[TBL] [Abstract][Full Text] [Related]
17. Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.
Kido H; Okumura Y; Takahashi E; Pan HY; Wang S; Chida J; Le TQ; Yano M
J Mol Genet Med; 2008 Nov; 3(1):167-75. PubMed ID: 19565019
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of murine beta-defensins (MBD-1, -2,- 3, and -4) in upper and lower airway mucosa of influenza virus infected mice.
Chong KT; Thangavel RR; Tang X
Virology; 2008 Oct; 380(1):136-43. PubMed ID: 18752820
[TBL] [Abstract][Full Text] [Related]
19. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
20. The influenza A virus matrix protein as a marker to monitor initial virus internalisation.
Eierhoff T; Ludwig S; Ehrhardt C
Biol Chem; 2009; 390(5-6):509-15. PubMed ID: 19335204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
